Showing results (51-60 of 413) with videos related to
Sort By:
Pageof 42
Journal of Clinical Gastroenterology|June 11, 2010
Obesity, metabolic syndrome, and microbiota: multiple interactionsHerbert TilgExpert Opinion on Therapeutic Targets|May 17, 2007
Inflammatory bowel diseases: meeting of the European Crohn's Colitis Organization, 1-3 March 2007, Innsbruck, AustriaHerbert TilgDigestive Diseases (Basel, Switzerland)|May 13, 2010
The role of cytokines in non-alcoholic fatty liver diseaseHerbert TilgCurrent Pharmaceutical Design|April 8, 2010
Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosisHerbert TilgEuropean Journal of Gastroenterology & Hepatology|December 3, 2008
Short bowel syndrome: searching for the proper dietHerbert TilgBiochemical and Biophysical Research Communications|February 19, 2017
Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytesKerstin Rufinatscha, Bernhard Radlinger, Jochen Dobner, et al.Obesity (Silver Spring, Md.)|March 28, 2009
Influence of visceral obesity and liver fat on vascular structure and function in obese subjectsWolfgang Sturm, Anton Sandhofer, Julia Engl, et al.The Journal of Nutritional Biochemistry|September 2, 2017
Fat-enriched rather than high-fructose diets promote whitening of adipose tissue in a sex-dependent mannerJochen Dobner, Claudia Ress, Kerstin Rufinatscha, et al.Cellular and Molecular Gastroenterology and Hepatology|October 8, 2021
Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic PharmacokineticsBernhard Texler, Andreas Zollner, Vera Reinstadler, et al.Journal of Crohn'S & Colitis|June 20, 2020
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative StudyAndreas Zollner, Andreas Schmiderer, Simon J Reider, et al.Pageof 42